1999
DOI: 10.1006/bbrc.1999.1163
|View full text |Cite
|
Sign up to set email alerts
|

Developmental Expression of Sarcoglycan Gene Products in Cultured Myocytes

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

2
41
0

Year Published

2000
2000
2014
2014

Publication Types

Select...
9

Relationship

1
8

Authors

Journals

citations
Cited by 35 publications
(44 citation statements)
references
References 23 publications
2
41
0
Order By: Relevance
“…In our experiments, it is unclear to what degree donor-derived nuclei have entered into the myogenic program. For example, dystrophin and sarcoglycan are expressed late in myotube differentiation in cell culture models (39), while MyoD and desmin serve as early markers of myoblast status. Because sarcoglycan is a late marker of myogenic specification, it is possible that stem cell-derived nuclei have partially differentiated into a myocyte lineage.…”
Section: Discussionmentioning
confidence: 99%
“…In our experiments, it is unclear to what degree donor-derived nuclei have entered into the myogenic program. For example, dystrophin and sarcoglycan are expressed late in myotube differentiation in cell culture models (39), while MyoD and desmin serve as early markers of myoblast status. Because sarcoglycan is a late marker of myogenic specification, it is possible that stem cell-derived nuclei have partially differentiated into a myocyte lineage.…”
Section: Discussionmentioning
confidence: 99%
“…Morris, Wolfson Centre for Inherited Neuromuscular Disease), 26 NCL-DYSB recognizing amino acids 321 to 494 (Novocastra Laboratories, Newcastle, UK), NCL-DYS1 recognizing amino acids 1181 to 1388 (Novocastra), MANDYS8 recognizing amino acids 1431 to 1505 (Sigma-Aldrich, St Louis, Mo), F22.9C5 recognizing amino acids 1840 to 2266 (Alexis, Lausen, Switzerland), or NCL-DYS2 recognizing amino acids 3669 to 3685 (Novocastra); mouse monoclonal antibodies against ␤-dystroglycan (NCL-b-DG, Novocastra), ␤-sarcoglycan (NCL-b-SG, Novocastra), ␥-sarcoglycan (NCL-g-SG, Novocastra), or ␦-sarcoglycan (DSG-1) 27 ; rabbit polyclonal antibodies against utrophin (UT-2), 28 ␣-sarcoglycan (␣-SG2), 29 or -calpain (anticalpain 1 large subunit domain IV; Sigma-Aldrich). The primary antibodies were labeled with fluorescein-conjugated goat anti-mouse or anti-rabbit immunoglobulin G (Molecular Probes, Eugene, Ore), and signals were recorded photographically with a confocal laser scanning microscope (TCSSP, Leica).…”
Section: Immunohistochemistrymentioning
confidence: 99%
“…We used a C2/4 cell line, a subclone of C2C12 mesenchymal cells, which retains only myogenic potency (43,44). Because C2/4 cells express Notch1 (see Fig.…”
Section: Fig 5 Nov Notch1mentioning
confidence: 99%